inclusion criteria: - all patients admitted at the covid-19 non-icu with a diagnosis of type 2 or secondary diabetes mellitus (dm) for whom intensive insulin therapy (basal plus at least two boluses) is indicated are eligible for the study.

inclusion criteria: - all patients admitted at the covid-19 non-icu with a diagnosis of type 2 or secondary diabetes mellitus (dm) for whom intensive insulin therapy (basal plus at least two boluses) is indicated are eligible for the study.